Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.34 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | PTGIR | P43119 | 3/20 | 0.33 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4557180 | 1.00 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL4557245 | 1.00 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL1593611 | 1.00 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL4557017 | 1.00 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL1594270 | 0.93 | ALDH1A1 (0.40) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL23327864 | 0.92 | SMN1; SMN2 (0.36) | ALDH1A1KMT2ASMN1; SMN2MEN1CA1 | |
| SCHEMBL17211371 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL2173884 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL20767261 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 | |
| SCHEMBL17435149 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KMT2ASMN1; SMN2MEN1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559529-B2 | NPY2 receptor agonists | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2026-02-24 | — | — | US | disclosed |
| US-20260015399-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2026-01-15 | — | — | US | disclosed |
| US-20260014257-A1 | THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22 | CYTOKI PHARMA APS (DK) | 2026-01-15 | — | — | US | disclosed |
| US-20250360186-A1 | DOSAGE REGIMEN FOR INTERLEUKIN-22 DERIVATIVES | CYTOKI PHARMA APS (DK) | 2025-11-27 | — | — | US | disclosed |
| EP-3448417-B1 | INSULIN DIMER-INCRETIN CONJUGATES | MERCK SHARP & DOHME LLC (US) | 2025-11-12 | — | — | EP | disclosed |
| US-12447211-B2 | Therapeutic derivatives of interleukin-22 | CYTOKI PHARMA APS (DK) | 2025-10-21 | — | — | US | disclosed |
| US-20250282824-A1 | Inhibitors of the Wnt Signaling Pathway and Uses Thereof | STICHTING VU (NL) | 2025-09-11 | — | — | US | disclosed |
| US-20250269046-A1 | CELLULAR UPTAKE OF LARGE BIOMOLECULES ENABLED BY CELL-SURFACE-REACTIVE CELL-PENETRATING PEPTIDE ADDITIVES | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2025-08-28 | — | — | US | disclosed |
| US-20250270253-A1 | SITE-SELECTIVE MODIFICATION OF PROTEINS | UNIVERSITY OF COPENHAGEN (DK) | 2025-08-28 | — | — | US | disclosed |
| EP-3740229-B1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN HAVING A PI OF BETWEEN 5.8 AND 8.5 AND A COPOLYAMINO ACID CARRYING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS | ADOCIA (FR) | 2025-04-09 | — | — | EP | disclosed |
| EP-2183273-A1 | CYCLIC DEPSIPEPTIDES | Novartis Ag (CH) | 2010-05-12 | — | — | EP | disclosed |
| WO-2010029159-A1 | METHOD OF ACYLATING A PEPTIDE OR PROTEIN | NOVO NORDISK A/S (DK) | 2010-03-18 | — | — | WO | disclosed |
| US-20090312197-A1 | PEPTIDE NUCLEIC ACIDS CONJUGATED WITH MULTI-AMINE LINKERS AND NUCLEIC ACID DETECTING DEVICE USING THE SAME | PANAGENE INC. (KR) | 2009-12-17 | — | — | US | disclosed |
| US-20090156472-A1 | Cyclic Depsipeptides | NOVARTIS AG (CH) | 2009-06-18 | — | — | US | disclosed |
| US-20090111730-A1 | Polypeptide protracting tags | NOVO NORDISK A/S (DK) | 2009-04-30 | — | — | US | disclosed |
| WO-2009024527-A1 | CYCLIC DEPSIPEPTIDES | NOVARTIS AG (CH) | 2009-02-26 | — | — | WO | disclosed |
| US-20080248461-A1 | PNA Probes, Kits, and Methods for Detecting Genotypes of Human Papillomavirus | PANAGENE INC. (KR) | 2008-10-09 | — | — | US | disclosed |
| US-20080233557-A1 | PNA Probes, Kits, and Methods for Detecting Lamivudine-Resistant Hepatitis B Viruses | PANAGENE INC. (KR) | 2008-09-25 | — | — | US | disclosed |
| EP-1765408-A2 | POLYPEPTIDE PROTRACTING TAGS COMPRISING A TETRAZOLE MOIETY | NOVO NORDISK A/S (DK) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006005667-A2 | POLYPEPTIDE PROTRACTING TAGS COMPRISING A TETRAZOLE MOIETY | NOVO NORDISK A/S (DK) | 2006-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312197-A1 | PEPTIDE NUCLEIC ACIDS CONJUGATED WITH MULTI-AMINE LINKERS AND NUCLEIC ACID DETECTING DEVICE USING THE SAME | NPPA, PARN, PARG | ALDH1A1 3477/4885KMT2A 548/4885SMN1; SMN2 3036/4885 |
| US-20080233557-A1 | PNA Probes, Kits, and Methods for Detecting Lamivudine-Resistant Hepatitis B Viruses | POLM, RNPEP, PNP | ALDH1A1 4268/4885KMT2A 3566/4885SMN1; SMN2 4734/4885 |
| US-20250282824-A1 | Inhibitors of the Wnt Signaling Pathway and Uses Thereof | WNT1, WNT3, WNT3A | ALDH1A1 4537/4885KMT2A 2588/4885SMN1; SMN2 3845/4885 |
| US-20080248461-A1 | PNA Probes, Kits, and Methods for Detecting Genotypes of Human Papillomavirus | POLI, PAIP1, PRAP1 | ALDH1A1 3802/4885KMT2A 3133/4885SMN1; SMN2 4389/4885 |
| US-20250269046-A1 | CELLULAR UPTAKE OF LARGE BIOMOLECULES ENABLED BY CELL-SURFACE-REACTIVE CELL-PENETRATING PEPTIDE ADDITIVES | GZMB, SLC7A5, SLC7A1 | ALDH1A1 3376/4885KMT2A 4012/4885SMN1; SMN2 3110/4885 |
| US-12447211-B2 | Therapeutic derivatives of interleukin-22 | IL2, IL2RA, IL23R | ALDH1A1 860/4885KMT2A 1666/4885SMN1; SMN2 3121/4885 |
| US-20250270253-A1 | SITE-SELECTIVE MODIFICATION OF PROTEINS | PTMS, DNPEP, AADAC | ALDH1A1 4292/4885KMT2A 252/4885SMN1; SMN2 4844/4885 |
| US-20250360186-A1 | DOSAGE REGIMEN FOR INTERLEUKIN-22 DERIVATIVES | IL2, FABP2, IL2RA | ALDH1A1 483/4885KMT2A 1972/4885SMN1; SMN2 4031/4885 |
| US-20090156472-A1 | Cyclic Depsipeptides | SERPINB1, ELANE, KLK7 | ALDH1A1 3924/4885KMT2A 3094/4885SMN1; SMN2 3808/4885 |
| US-20090111730-A1 | Polypeptide protracting tags | LNPEP, FGB, ENPEP | ALDH1A1 3105/4885KMT2A 4689/4885SMN1; SMN2 1647/4885 |
| US-20260015399-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | NPY1R, NPY2R, NPY5R | ALDH1A1 4878/4885KMT2A 2872/4885SMN1; SMN2 2607/4885 |
| US-12559529-B2 | NPY2 receptor agonists | NPY2R, NPY5R, NPY1R | ALDH1A1 4624/4885KMT2A 679/4885SMN1; SMN2 1470/4885 |
| US-20260014257-A1 | THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22 | IL2, IL23R, IL36G | ALDH1A1 2432/4885KMT2A 1926/4885SMN1; SMN2 3876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.